301 related articles for article (PubMed ID: 25130542)
1. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
[TBL] [Abstract][Full Text] [Related]
2. Optimization of magnetic beads for maldi-TOF MS analysis.
Qiu F; Liu HY; Zhang XJ; Tian YP
Front Biosci (Landmark Ed); 2009 Jan; 14(10):3712-23. PubMed ID: 19273304
[TBL] [Abstract][Full Text] [Related]
3. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
4. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
[TBL] [Abstract][Full Text] [Related]
5. Plasma Peptidome Pattern of Breast Cancer Using Magnetic Beads-Based Plasma Fractionation and MALDI-TOF MS: A Case Control Study in Egypt.
Zaki A; Ramadan RA; Moez P; Ghareeb H; Elkarmouty A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):175-184. PubMed ID: 30678429
[TBL] [Abstract][Full Text] [Related]
6. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
[TBL] [Abstract][Full Text] [Related]
7. Optimization and evaluation of magnetic bead separation combined with matrix-assisted laser desorption/ionization time-of-flight mass spectroscopy (MALDI-TOF MS) for proteins profiling of peritoneal dialysis effluent.
Guo N; Wen Q; Li ZJ; Xu RC; Peng FF; Yu XQ
Int J Mol Sci; 2014 Jan; 15(1):1162-75. PubMed ID: 24441570
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
[TBL] [Abstract][Full Text] [Related]
9. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
10. Identification of candidate biomarker mass (m/z) ranges in serous ovarian adenocarcinoma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
Periyasamy A; Gopisetty G; Veluswami S; Joyimallaya Subramanium M; Thangarajan R
Biomarkers; 2015; 20(5):292-8. PubMed ID: 26329525
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the raw serum peptidomic pattern in glioma patients.
Li Z; Lu H; Yang J; Zeng X; Zhao L; Li H; Liao Q; Peng S; Zhou M; Wu M; Xiang J; Wang Y; Li G
Clin Chim Acta; 2013 Oct; 425():221-6. PubMed ID: 23954773
[TBL] [Abstract][Full Text] [Related]
13. Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures.
Velstra B; van der Burgt YE; Mertens BJ; Mesker WE; Deelder AM; Tollenaar RA
J Cancer Res Clin Oncol; 2012 Dec; 138(12):1983-92. PubMed ID: 22763645
[TBL] [Abstract][Full Text] [Related]
14. Identification of urinary biomarkers for type 2 diabetes using bead-based proteomic approach.
Chu L; Fu G; Meng Q; Zhou H; Zhang M
Diabetes Res Clin Pract; 2013 Aug; 101(2):187-93. PubMed ID: 23769013
[TBL] [Abstract][Full Text] [Related]
15. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
16. Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads.
Zhang X; Yuan Z; Shen B; Zhu M; Liu C; Xu W
Clin Exp Med; 2012 Sep; 12(3):145-51. PubMed ID: 21922190
[TBL] [Abstract][Full Text] [Related]
17. Proteomic expression profiling and identification of serum proteins using immobilized trypsin beads with MALDI-TOF/TOF.
Karbassi ID; Nyalwidhe JO; Wilkins CE; Cazares LH; Lance RS; Semmes OJ; Drake RR
J Proteome Res; 2009 Sep; 8(9):4182-92. PubMed ID: 19603828
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers screening between preoperative and postoperative patients in pancreatic cancer.
Li P; Yang J; Ma QY; Wu Z; Huang C; Li XQ; Wang Z
Asian Pac J Cancer Prev; 2013; 14(7):4161-5. PubMed ID: 23991970
[TBL] [Abstract][Full Text] [Related]
19. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.
Liu C; Pan C; Shen J; Wang H; Yong L
Int J Med Sci; 2011 Jan; 8(1):39-47. PubMed ID: 21234268
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
